Kuraray (OTCMKTS:KURRY) Shares Gap Down - What's Next?

Key Points

• Kuraray Co. shares opened at $33.62 on Tuesday, down from a previous close of $35.71, indicating a 5.8% decline.
• The company reported earnings of $0.04 EPS for the last quarter, with revenue totaling $1.42 billion and a net margin of 1.90%.
• Kuraray has a market capitalization of $3.64 billion and a low beta of 0.08, suggesting low volatility in its stock performance.

Kuraray Co. (OTCMKTS:KURRY - Get Free Report)'s share price gapped down prior to trading on Tuesday . The stock had previously closed at $35.71, but opened at $33.62. Kuraray shares last traded at $33.62, with a volume of 113 shares changing hands.

Kuraray Stock Down 5.8%

The firm's 50-day moving average price is $36.41 and its 200 day moving average price is $36.63. The firm has a market capitalization of $3.64 billion, a price-to-earnings ratio of 34.31 and a beta of 0.08. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.75 and a quick ratio of 1.45.

Kuraray (OTCMKTS:KURRY - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported $0.04 earnings per share (EPS) for the quarter. Kuraray had a net margin of 1.90% and a return on equity of 5.41%. The firm had revenue of $1.42 billion for the quarter.

Kuraray Company Profile

Kuraray Co, Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.